Perbedaan Fortune Mate Indonesia Tbk dan Merck Tbk.: Fortune Mate Indonesia Tbk diperdagangkan di Rp252 (kapitalisasi pasar 1,59 T, volume 24 jam 142,4 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.800 (kapitalisasi pasar 1,68 T, volume 24 jam 33,3 rb). Perbedaan utamanya: Fortune Mate Indonesia Tbk dan Merck Tbk. berukuran mirip dari sisi kapitalisasi pasar, dan Fortune Mate Indonesia Tbk lebih aktif diperdagangkan (142,4 rb vs 33,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| FMII | MERK | |
|---|---|---|
Kapitalisasi Pasar | 1,59 T | 1,68 T |
Volume | 142,4 rb | 33,3 rb |
Lot | 1,42 rb | 333 |
Perputaran | 35,31 jt | 126,46 jt |
Harga Rata-rata | 247,99 | 3.797,72 |
Nilai Transaksi | 35,31 jt | 126,46 jt |
Harga Ekuilibrium Indikatif | 252 | 3.800 |
Volume Ekuilibrium Indikatif | 33 | 9 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Selengkapnya di halaman FMII →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →